{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:34:51Z","timestamp":1793266491049,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["1S10OD030254\\u201301A1"],"award-info":[{"award-number":["1S10OD030254\\u201301A1"]}],"id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA295774"],"award-info":[{"award-number":["R01CA295774"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD028540"],"award-info":[{"award-number":["S10OD028540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA270623"],"award-info":[{"award-number":["R01CA270623"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI152655"],"award-info":[{"award-number":["R01AI152655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA278608"],"award-info":[{"award-number":["R01CA278608"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2P30AI036219\\u201326A1"],"award-info":[{"award-number":["2P30AI036219\\u201326A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.actbio.2025.11.017","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:40:59Z","timestamp":1763347259000},"page":"521-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Harnessing albumin as a carrier for the delivery of anti-HIV drugs to the lymphatic system"],"prefix":"10.1016","volume":"209","author":[{"given":"Ziqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Raymond E.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Joseph","family":"Oberly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-7016","authenticated-orcid":false,"given":"Daniel J.","family":"Bain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-1382","authenticated-orcid":false,"given":"Thomas D","family":"Nolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses T.","family":"Bility","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-503X","authenticated-orcid":false,"given":"Robbie B","family":"Mailliard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.actbio.2025.11.017_bib0001","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm0703-839","article-title":"HIV and AIDS: 20 years of science","volume":"9","author":"Fauci","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2025.11.017_bib0002","first-page":"231","article-title":"Reflections on 40 years of AIDS, advances in clinical immunology, medical microbiology","author":"De Cock","year":"2021","journal-title":"COVID-19 Big Data"},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV infection","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0004","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tips.2021.10.004","article-title":"Update and latest advances in antiretroviral therapy","volume":"43","author":"Men\u00e9ndez-Arias","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.actbio.2025.11.017_bib0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/hiv.13268","article-title":"Major revision version 11.0 of the European AIDS clinical society guidelines 2021","volume":"23","author":"Ryom","year":"2022","journal-title":"HIV. Med."},{"issue":"16","key":"10.1016\/j.actbio.2025.11.017_bib0006","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society\u2013USA Panel","volume":"324","author":"Saag","year":"2020","journal-title":"JAMa"},{"issue":"5","key":"10.1016\/j.actbio.2025.11.017_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097482","article-title":"Efficacy of initial antiretroviral therapy for HIV-1 infection in adults: a systematic review and meta-analysis of 114 studies with up to 144 weeks' follow-up","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS. One"},{"issue":"3","key":"10.1016\/j.actbio.2025.11.017_bib0008","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/COH.0000000000000535","article-title":"HIV-1 phylogeny during suppressive antiretroviral therapy","volume":"14","author":"Bale","year":"2019","journal-title":"Curr. Opin. HIV. AIDS"},{"issue":"9","key":"10.1016\/j.actbio.2025.11.017_bib0009","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40265-020-01322-y","article-title":"Novel approaches towards a functional cure of HIV\/AIDS","volume":"80","author":"Bailon","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0010","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1080\/21505594.2021.2004743","article-title":"Persistent low-level viremia in persons living with HIV undertreatment: an unresolved status","volume":"12","author":"Crespo-Bermejo","year":"2021","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.actbio.2025.11.017_bib0011","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1570162X20666220216102943","article-title":"Low-level viremia in treated HIV-1 infected patients: advances and challenges","volume":"20","author":"Bai","year":"2022","journal-title":"Curr. HIV Res."},{"issue":"6","key":"10.1016\/j.actbio.2025.11.017_bib0012","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/apc.2023.0028","article-title":"HIV tissue reservoirs: current advances in research","volume":"37","author":"Li","year":"2023","journal-title":"AIDS Patient. Care STDS."},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12985-019-1276-8","article-title":"The forces driving clonal expansion of the HIV-1 latent reservoir","volume":"17","author":"Liu","year":"2020","journal-title":"Virol. J."},{"issue":"7","key":"10.1016\/j.actbio.2025.11.017_bib0014","article-title":"Tissue-specific differences in HIV DNA levels and mechanisms that govern HIV transcription in blood, gut, genital tract and liver in ART-treated women","volume":"24","author":"Moron-Lopez","year":"2021","journal-title":"Afr. J. Reprod. Gynaecol. Endosc."},{"issue":"6","key":"10.1016\/j.actbio.2025.11.017_bib0015","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"Fletcher","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0016","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-065X.1997.tb00966.x","article-title":"The anatomical basis of intestinal immunity","volume":"156","author":"Mowat","year":"1997","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0017","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41467-022-28727-5","article-title":"First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody","volume":"13","author":"Beckford-Vera","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.actbio.2025.11.017_bib0018","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","article-title":"Material design for lymph node drug delivery","volume":"4","author":"Schudel","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.actbio.2025.11.017_bib0019","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/v12040412","article-title":"The potential of long-acting, tissue-targeted synthetic nanotherapy for delivery of antiviral therapy against HIV infection","volume":"12","author":"Halling Folkmar Andersen","year":"2020","journal-title":"Viruses"},{"issue":"1\u20132","key":"10.1016\/j.actbio.2025.11.017_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00150-8","article-title":"The physiology of the lymphatic system","volume":"50","author":"Swartz","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.11.017_bib0021","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1208\/s12248-012-9367-0","article-title":"Mechanistic determinants of biotherapeutics absorption following SC administration","volume":"14","author":"Richter","year":"2012","journal-title":"AAPS. J."},{"issue":"6","key":"10.1016\/j.actbio.2025.11.017_bib0022","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/QAD.0000000000001405","article-title":"Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma","volume":"31","author":"Kraft","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.actbio.2025.11.017_bib0023","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s13346-015-0254-y","article-title":"Systems approach to targeted and long-acting HIV\/AIDS therapy","volume":"5","author":"Ho","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.actbio.2025.11.017_bib0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpb.2018.04.014","article-title":"Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy","volume":"138","author":"Gao","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.actbio.2025.11.017_bib0025","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s10924-025-03545-0","article-title":"Preparation of starch biopolymer decorated bimetallic metal-organic framework (Mn-Zn) bio-nanocomposite for pH-controlled drug delivery","volume":"33","author":"Pooresmaeil","year":"2025","journal-title":"J. Polym. Env."},{"issue":"3","key":"10.1016\/j.actbio.2025.11.017_bib0026","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/v15030647","article-title":"Advances in antiviral delivery systems and chitosan-based polymeric and nanoparticulate antivirals and antiviral carriers","volume":"15","author":"\u017digrayov\u00e1","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/aid.2014.0210","article-title":"Anti-HIV drug-combination nanoparticles enhance plasma drug exposure duration as well as triple-drug combination levels in cells within lymph nodes and blood in primates","volume":"31","author":"Freeling","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"5\u20136","key":"10.1016\/j.actbio.2025.11.017_bib0028","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/1061186X.2018.1433681","article-title":"Indocyanine green nanoparticles undergo selective lymphatic uptake, distribution and retention and enable detailed mapping of lymph vessels, nodes and abnormalities","volume":"26","author":"Kraft","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actbio.2025.11.017_bib0029","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2018.02.003","article-title":"Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation","volume":"275","author":"Kraft","year":"2018","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0030","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7150\/thno.68182","article-title":"Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics","volume":"12","author":"Wen","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0031","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41467-017-02191-y","article-title":"Albumin\/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.actbio.2025.11.017_bib0032","doi-asserted-by":"crossref","first-page":"243","DOI":"10.7150\/thno.14322","article-title":"Chemical conjugation of Evans Blue derivative: a strategy to develop long-acting therapeutics through albumin binding","volume":"6","author":"Chen","year":"2016","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.actbio.2025.11.017_bib0033","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/acs.jmedchem.9b00128","article-title":"Fuplatin: an efficient and low-toxic dual-prodrug","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actbio.2025.11.017_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124164","article-title":"Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action","volume":"1241","author":"West","year":"2024","journal-title":"J. Chromatogr. B"},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-0270(83)90050-X","article-title":"Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues","volume":"8","author":"Saria","year":"1983","journal-title":"J. Neurosci. Methods"},{"issue":"2\u20133","key":"10.1016\/j.actbio.2025.11.017_bib0036","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0021-9150(82)90040-5","article-title":"Binding properties of circulating Evans blue in rabbits as determined by disc electrophoresis","volume":"43","author":"Lindner","year":"1982","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.actbio.2025.11.017_bib0037","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1021\/acs.bioconjchem.6b00487","article-title":"Albumin-binding Evans Blue derivatives for diagnostic imaging and production of long-acting therapeutics","volume":"27","author":"Jacobson","year":"2016","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.actbio.2025.11.017_bib0038","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.2042-7158.1980.tb12991.x","article-title":"Aspirin binding and the effect of albumin on spontaneous and enzyme-catalysed hydrolysis","volume":"32","author":"AARONS","year":"1980","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.actbio.2025.11.017_bib0039","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jps.2600670530","article-title":"Hydrolysis and protein binding of melphalan","volume":"67","author":"Chang","year":"1978","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2025.11.017_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1099-081X(199904)20:3<131::AID-BDD166>3.0.CO;2-X","article-title":"Interaction of human serum albumin with furosemide glucuronide: a role of albumin in isomerization, hydrolysis, reversible binding and irreversible binding of a 1-O-acyl glucuronide metabolite","volume":"20","author":"Mizuma","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"issue":"4","key":"10.1016\/j.actbio.2025.11.017_bib0041","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of Human Immunodeficiency Virus type 1","volume":"72","author":"Platt Emily","year":"1998","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.actbio.2025.11.017_bib0042","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant Human Immunodeficiency Virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125008396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125008396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:52:51Z","timestamp":1793263971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125008396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"alternative-id":["S1742706125008396"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.11.017","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing albumin as a carrier for the delivery of anti-HIV drugs to the lymphatic system","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}